TDG is a novel tumor suppressor of liver malignancies

2Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In a recent publication, we demonstrated that conditional deletion of the gene encoding thymine DNA glycosylase (TDG) leads to a late onset of hepatocellular carcinoma (HCC). TDG loss causes disruption in active DNA demethylation in the liver and dysregulation of the farnesoid X receptor and small heterodimer partner (FXR-SHP) regulatory cascade. This leads to a loss of bile acid and glucose homeostasis, which predisposes mice to HCC.

Cite

CITATION STYLE

APA

Hassan, H. M., Isovic, M., Underhill, M. T., & Torchia, J. (2020). TDG is a novel tumor suppressor of liver malignancies. Molecular and Cellular Oncology, 7(4). https://doi.org/10.1080/23723556.2020.1768819

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free